RxDoctor Payments DataLook up a doctor →

William Hamilton, MD

Adult Reconstructive Orthopaedic Surgery · Alexandria, VANPI 1811944143

Payments from drug & device makers

$9,320,570in general payments, 2019–2025

Across 336 payments — averaging $27,740 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Depuy Synthes Products, Inc.$8.7M
  • Medical Device Business Services, Inc.$470K
  • Zimmer Biomet$66K
  • Total Joint Orthopedics, Inc.$64K
  • Onkos Surgical, Inc.$16K
  • Regeneron$2K
  • plus $982 from 9 others
$569in research payments, 2019–2025

Across 4 payments — averaging $142.19 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Zimmer Biomet$569

What the payments were for

  • Royalty or licence$8,741,66294%
  • Consulting fees$493,9845%
  • Travel & lodging$10,7320%
  • Food & beverage$6,9430%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,320,570 in reported general payments places this provider in the 95th percentile of 58 adult reconstructive orthopaedic surgery providers in Virginia.

See all adult reconstructive orthopaedic surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$608,863
Medicare patients
754
Services billed
3,716

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib81$2,584
Meloxicam31$138

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Alexandria

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →